Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Trial on the Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Modified Ban Xia Xie Xin Decoction

NCT05586464 is registered in ClinicalTrials.gov with Liaocheng People's Hospital as lead sponsor.

NCT NCT05586464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05586464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Trial on the Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Modified Ban Xia Xie Xin Decoction
Lead sponsor
Liaocheng People's Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
November 1, 2022
Completion date
September 30, 2024
Enrollment
600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

eradication, helicobacter pylori infection, traditional chinese medicine